CN104784739A - 一种载磺胺嘧啶银复合抗菌敷料的制备方法 - Google Patents
一种载磺胺嘧啶银复合抗菌敷料的制备方法 Download PDFInfo
- Publication number
- CN104784739A CN104784739A CN201510155319.6A CN201510155319A CN104784739A CN 104784739 A CN104784739 A CN 104784739A CN 201510155319 A CN201510155319 A CN 201510155319A CN 104784739 A CN104784739 A CN 104784739A
- Authority
- CN
- China
- Prior art keywords
- silver sulfadiazine
- bacterial cellulose
- preparation
- antiseptic dressing
- sodium alginate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 229960003600 silver sulfadiazine Drugs 0.000 title claims abstract description 76
- UEJSSZHHYBHCEL-UHFFFAOYSA-N silver(1+) sulfadiazinate Chemical compound [Ag+].C1=CC(N)=CC=C1S(=O)(=O)[N-]C1=NC=CC=N1 UEJSSZHHYBHCEL-UHFFFAOYSA-N 0.000 title claims abstract description 39
- 238000002360 preparation method Methods 0.000 title claims abstract description 20
- 239000002131 composite material Substances 0.000 title abstract description 17
- 230000000844 anti-bacterial effect Effects 0.000 title abstract description 15
- 229920002749 Bacterial cellulose Polymers 0.000 claims abstract description 47
- 239000005016 bacterial cellulose Substances 0.000 claims abstract description 47
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 claims abstract description 31
- 239000000661 sodium alginate Substances 0.000 claims abstract description 31
- 235000010413 sodium alginate Nutrition 0.000 claims abstract description 31
- 229940005550 sodium alginate Drugs 0.000 claims abstract description 31
- 239000007788 liquid Substances 0.000 claims abstract description 15
- 239000000725 suspension Substances 0.000 claims abstract description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 9
- 238000000855 fermentation Methods 0.000 claims abstract description 8
- 230000004151 fermentation Effects 0.000 claims abstract description 8
- 238000004108 freeze drying Methods 0.000 claims abstract description 7
- 235000002837 Acetobacter xylinum Nutrition 0.000 claims abstract description 6
- 241001136169 Komagataeibacter xylinus Species 0.000 claims abstract 2
- 230000002421 anti-septic effect Effects 0.000 claims description 39
- -1 silver sulfadiazine compound Chemical class 0.000 claims description 38
- 238000000034 method Methods 0.000 claims description 12
- 241000894006 Bacteria Species 0.000 claims description 8
- 239000001963 growth medium Substances 0.000 claims description 8
- 230000008569 process Effects 0.000 claims description 8
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 7
- 239000002609 medium Substances 0.000 claims description 6
- 238000011218 seed culture Methods 0.000 claims description 6
- 238000007711 solidification Methods 0.000 claims description 6
- 230000008023 solidification Effects 0.000 claims description 6
- 239000011248 coating agent Substances 0.000 claims description 5
- 238000000576 coating method Methods 0.000 claims description 5
- 150000001875 compounds Chemical class 0.000 claims description 5
- 239000008367 deionised water Substances 0.000 claims description 5
- 229910021641 deionized water Inorganic materials 0.000 claims description 5
- 238000002156 mixing Methods 0.000 claims description 5
- 239000000203 mixture Substances 0.000 claims description 5
- 230000004913 activation Effects 0.000 claims description 4
- 238000001914 filtration Methods 0.000 claims description 4
- 238000004132 cross linking Methods 0.000 claims description 3
- 239000002054 inoculum Substances 0.000 claims description 3
- 241000589516 Pseudomonas Species 0.000 claims description 2
- 238000013019 agitation Methods 0.000 claims description 2
- 230000003292 diminished effect Effects 0.000 claims description 2
- 238000011017 operating method Methods 0.000 claims description 2
- 230000029663 wound healing Effects 0.000 abstract description 7
- 241000191967 Staphylococcus aureus Species 0.000 abstract description 6
- 241000222122 Candida albicans Species 0.000 abstract description 5
- 241000588724 Escherichia coli Species 0.000 abstract description 5
- 229940095731 candida albicans Drugs 0.000 abstract description 5
- 230000005764 inhibitory process Effects 0.000 abstract description 3
- 238000004519 manufacturing process Methods 0.000 abstract description 2
- 238000009210 therapy by ultrasound Methods 0.000 abstract description 2
- 239000003513 alkali Substances 0.000 abstract 1
- 230000014759 maintenance of location Effects 0.000 abstract 1
- 230000036560 skin regeneration Effects 0.000 abstract 1
- 230000003068 static effect Effects 0.000 abstract 1
- 238000005406 washing Methods 0.000 abstract 1
- 206010052428 Wound Diseases 0.000 description 21
- 208000027418 Wounds and injury Diseases 0.000 description 21
- 239000000499 gel Substances 0.000 description 13
- 238000005033 Fourier transform infrared spectroscopy Methods 0.000 description 9
- 230000000694 effects Effects 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- 244000235858 Acetobacter xylinum Species 0.000 description 4
- 230000003321 amplification Effects 0.000 description 4
- 230000003115 biocidal effect Effects 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 239000000835 fiber Substances 0.000 description 4
- 238000003199 nucleic acid amplification method Methods 0.000 description 4
- 230000001954 sterilising effect Effects 0.000 description 4
- 239000006150 trypticase soy agar Substances 0.000 description 4
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 230000035876 healing Effects 0.000 description 3
- 244000005700 microbiome Species 0.000 description 3
- 238000004659 sterilization and disinfection Methods 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- ALYNCZNDIQEVRV-UHFFFAOYSA-N 4-aminobenzoic acid Chemical compound NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 description 2
- 229920001661 Chitosan Polymers 0.000 description 2
- 102000053602 DNA Human genes 0.000 description 2
- 108020004414 DNA Proteins 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- 239000001888 Peptone Substances 0.000 description 2
- 108010080698 Peptones Proteins 0.000 description 2
- FOIXSVOLVBLSDH-UHFFFAOYSA-N Silver ion Chemical compound [Ag+] FOIXSVOLVBLSDH-UHFFFAOYSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 229960000583 acetic acid Drugs 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 239000012876 carrier material Substances 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 239000012531 culture fluid Substances 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000000017 hydrogel Substances 0.000 description 2
- 238000011081 inoculation Methods 0.000 description 2
- 239000012567 medical material Substances 0.000 description 2
- 230000036407 pain Effects 0.000 description 2
- 235000019319 peptone Nutrition 0.000 description 2
- 230000035699 permeability Effects 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 230000001681 protective effect Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- SEEPANYCNGTZFQ-UHFFFAOYSA-N sulfadiazine Chemical compound C1=CC(N)=CC=C1S(=O)(=O)NC1=NC=CC=N1 SEEPANYCNGTZFQ-UHFFFAOYSA-N 0.000 description 2
- 229960004306 sulfadiazine Drugs 0.000 description 2
- 229920001817 Agar Polymers 0.000 description 1
- 238000009631 Broth culture Methods 0.000 description 1
- 206010051548 Burn infection Diseases 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 108010076119 Caseins Proteins 0.000 description 1
- 108010059892 Cellulase Proteins 0.000 description 1
- 241000192125 Firmicutes Species 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 229920001410 Microfiber Polymers 0.000 description 1
- 108090000526 Papain Proteins 0.000 description 1
- 241000199919 Phaeophyceae Species 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 206010042566 Superinfection Diseases 0.000 description 1
- 206010053615 Thermal burn Diseases 0.000 description 1
- 230000001133 acceleration Effects 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- 229960004050 aminobenzoic acid Drugs 0.000 description 1
- 230000000843 anti-fungal effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000000941 anti-staphylcoccal effect Effects 0.000 description 1
- 229940121375 antifungal agent Drugs 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 159000000007 calcium salts Chemical class 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 229940106157 cellulase Drugs 0.000 description 1
- 230000008166 cellulose biosynthesis Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 231100000481 chemical toxicant Toxicity 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 230000002860 competitive effect Effects 0.000 description 1
- 239000004567 concrete Substances 0.000 description 1
- 230000009514 concussion Effects 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 230000007849 functional defect Effects 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 230000003760 hair shine Effects 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 238000002329 infrared spectrum Methods 0.000 description 1
- 238000005342 ion exchange Methods 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 241001515939 male-killing Rickettsia from Adalia bipunctata Species 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 239000003658 microfiber Substances 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 1
- 235000019796 monopotassium phosphate Nutrition 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- 239000002086 nanomaterial Substances 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 210000000496 pancreas Anatomy 0.000 description 1
- 229940055729 papain Drugs 0.000 description 1
- 235000019834 papain Nutrition 0.000 description 1
- 238000011056 performance test Methods 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- PJNZPQUBCPKICU-UHFFFAOYSA-N phosphoric acid;potassium Chemical compound [K].OP(O)(O)=O PJNZPQUBCPKICU-UHFFFAOYSA-N 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 125000000714 pyrimidinyl group Chemical group 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 210000000582 semen Anatomy 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 238000013268 sustained release Methods 0.000 description 1
- 239000012730 sustained-release form Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 230000000472 traumatic effect Effects 0.000 description 1
- 238000004879 turbidimetry Methods 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
Landscapes
- Materials For Medical Uses (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Medicinal Preparation (AREA)
Abstract
Description
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510155319.6A CN104784739B (zh) | 2015-04-03 | 2015-04-03 | 一种载磺胺嘧啶银复合抗菌敷料的制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510155319.6A CN104784739B (zh) | 2015-04-03 | 2015-04-03 | 一种载磺胺嘧啶银复合抗菌敷料的制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104784739A true CN104784739A (zh) | 2015-07-22 |
CN104784739B CN104784739B (zh) | 2017-11-24 |
Family
ID=53550218
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510155319.6A Expired - Fee Related CN104784739B (zh) | 2015-04-03 | 2015-04-03 | 一种载磺胺嘧啶银复合抗菌敷料的制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104784739B (zh) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108066766A (zh) * | 2017-12-04 | 2018-05-25 | 北京派尔特医疗科技股份有限公司 | 一种丝材微孔陶瓷层载药方法及系统 |
CN108686266A (zh) * | 2018-06-06 | 2018-10-23 | 重庆科技学院 | 一种三维多孔微支架组装单元的制备方法 |
CN110201102A (zh) * | 2019-07-17 | 2019-09-06 | 湖北特必达生物医疗科技有限公司 | 一种复合生物抗菌材料及其制备方法 |
CN115025280A (zh) * | 2022-07-05 | 2022-09-09 | 中山大学附属第七医院(深圳) | 一种细菌水解酶响应型水凝胶抗菌敷料及其制备方法 |
CN116376076A (zh) * | 2023-03-27 | 2023-07-04 | 西安工程大学 | 海藻酸铜封装细菌纤维素/纳米银复合抗菌薄膜、制备及应用 |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101215388A (zh) * | 2008-01-15 | 2008-07-09 | 东华大学 | 一种细菌纤维素复合膜的制备方法 |
CN101613893A (zh) * | 2009-07-29 | 2009-12-30 | 武汉科技学院 | 细菌纤维素/海藻酸钠复合纤维及其制备方法 |
CN101905031A (zh) * | 2010-07-16 | 2010-12-08 | 北京科技大学 | 一种磺胺嘧啶银/细菌纤维素复合伤口敷料的制备方法 |
CN102961777A (zh) * | 2012-12-11 | 2013-03-13 | 北京科技大学 | 改性纳米纤维素多孔复合型高吸渗止血敷料的制备方法 |
CN103041438A (zh) * | 2012-12-31 | 2013-04-17 | 钟春燕 | 一种治疗糖尿病足溃疡的湿性抗菌水凝胶敷料 |
CN104072809A (zh) * | 2014-06-20 | 2014-10-01 | 南京林业大学 | 一种氧化石墨烯/细菌纤维素抗菌复合材料的制备方法 |
-
2015
- 2015-04-03 CN CN201510155319.6A patent/CN104784739B/zh not_active Expired - Fee Related
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101215388A (zh) * | 2008-01-15 | 2008-07-09 | 东华大学 | 一种细菌纤维素复合膜的制备方法 |
CN101613893A (zh) * | 2009-07-29 | 2009-12-30 | 武汉科技学院 | 细菌纤维素/海藻酸钠复合纤维及其制备方法 |
CN101905031A (zh) * | 2010-07-16 | 2010-12-08 | 北京科技大学 | 一种磺胺嘧啶银/细菌纤维素复合伤口敷料的制备方法 |
CN102961777A (zh) * | 2012-12-11 | 2013-03-13 | 北京科技大学 | 改性纳米纤维素多孔复合型高吸渗止血敷料的制备方法 |
CN103041438A (zh) * | 2012-12-31 | 2013-04-17 | 钟春燕 | 一种治疗糖尿病足溃疡的湿性抗菌水凝胶敷料 |
CN104072809A (zh) * | 2014-06-20 | 2014-10-01 | 南京林业大学 | 一种氧化石墨烯/细菌纤维素抗菌复合材料的制备方法 |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108066766A (zh) * | 2017-12-04 | 2018-05-25 | 北京派尔特医疗科技股份有限公司 | 一种丝材微孔陶瓷层载药方法及系统 |
CN108066766B (zh) * | 2017-12-04 | 2021-08-31 | 北京派尔特医疗科技股份有限公司 | 一种丝材微孔陶瓷层载药方法及系统 |
CN108686266A (zh) * | 2018-06-06 | 2018-10-23 | 重庆科技学院 | 一种三维多孔微支架组装单元的制备方法 |
CN110201102A (zh) * | 2019-07-17 | 2019-09-06 | 湖北特必达生物医疗科技有限公司 | 一种复合生物抗菌材料及其制备方法 |
CN115025280A (zh) * | 2022-07-05 | 2022-09-09 | 中山大学附属第七医院(深圳) | 一种细菌水解酶响应型水凝胶抗菌敷料及其制备方法 |
CN115025280B (zh) * | 2022-07-05 | 2023-09-26 | 中山大学附属第七医院(深圳) | 一种细菌水解酶响应型水凝胶抗菌敷料及其制备方法 |
CN116376076A (zh) * | 2023-03-27 | 2023-07-04 | 西安工程大学 | 海藻酸铜封装细菌纤维素/纳米银复合抗菌薄膜、制备及应用 |
CN116376076B (zh) * | 2023-03-27 | 2024-03-22 | 西安工程大学 | 海藻酸铜封装细菌纤维素/纳米银复合抗菌薄膜、制备及应用 |
Also Published As
Publication number | Publication date |
---|---|
CN104784739B (zh) | 2017-11-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102552965B (zh) | 一种在线培养制备纳米纤维素抗菌复合材料的方法 | |
CN104784739A (zh) | 一种载磺胺嘧啶银复合抗菌敷料的制备方法 | |
CN105311668B (zh) | 一种细菌纤维素复合氧化亚铜抗菌敷料及其制备方法 | |
CN105435300B (zh) | 一种含纳米丝素蛋白的抑菌医用敷料 | |
CN104072809A (zh) | 一种氧化石墨烯/细菌纤维素抗菌复合材料的制备方法 | |
WO2005003366A1 (en) | A method for the production of bacterial cellulose | |
CN102660461A (zh) | 一种缩短烟叶发酵周期的微生物制剂及其应用 | |
CN103194856B (zh) | 抗菌、伤口愈合作用的壳聚糖/丝胶复合纳米纤维的制备方法 | |
CN103613449B (zh) | 一种二级发酵生产高缓释肥效肥料及其制备方法 | |
KR101385501B1 (ko) | 화장용 바이오셀룰로오스 시트의 제조방법 및 이를 이용하여 제조된 화장용 바이오셀룰로오스 시트 | |
JP2016529887A (ja) | 天然の小型発酵槽として機能する可変的体積の高吸収性アグロペレット中に担持される固体接種材料および獲得方法 | |
CN101502271B (zh) | 一种防治害虫的真菌颗粒剂的制造方法 | |
CN105381500A (zh) | 一种功能性创面修复材料及其制备方法 | |
CN110720638A (zh) | 一种益生菌粉及其生产方法 | |
CN101705099B (zh) | 土壤治理用的复合材料及制备方法 | |
CN107522567A (zh) | 一种苹果专用生物肥料的制备方法 | |
CN103007335A (zh) | 壳寡糖/细菌纤维素海绵的制备方法 | |
CN104846050B (zh) | 一种具有抗菌性能的细菌纤维素的制备方法 | |
CN106906171B (zh) | 一种苹果树腐烂病生防菌剂的制备方法 | |
CN111838677A (zh) | 可培养的肠道菌微胶囊及其制备方法 | |
CN109721757A (zh) | 一种医用硅橡胶及其制备方法与应用、硅橡胶产品 | |
CN105384957A (zh) | 一种基于细菌纤维素的有序纳米纤维膜的制备方法 | |
CN109045342A (zh) | 利用大豆糖蜜生产的细菌纤维素制备壳聚糖-纤维素纳米复合膜伤口敷料 | |
CN107044054A (zh) | 一种原位细菌纤维素/羽绒保温材料及其制备方法 | |
CN109529092A (zh) | 一种细菌纤维素基湿性抗菌敷料及制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
EXSB | Decision made by sipo to initiate substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
EE01 | Entry into force of recordation of patent licensing contract |
Application publication date: 20150722 Assignee: NANJING QIUPU BIOLOGICAL TECHNOLOGY CO.,LTD. Assignor: Nanjing Forestry University Contract record no.: 2019320000114 Denomination of invention: Preparation method of composite antibacterial dressing loaded with silver sulfadiazine Granted publication date: 20171124 License type: Common License Record date: 20190424 Application publication date: 20150722 Assignee: KELEIBOSHI ENVIRONMENTAL PROTECTION TECHNOLOGY (SUZHOU) CO.,LTD. Assignor: Nanjing Forestry University Contract record no.: 2019320000111 Denomination of invention: Preparation method of composite antibacterial dressing loaded with silver sulfadiazine Granted publication date: 20171124 License type: Common License Record date: 20190423 |
|
EE01 | Entry into force of recordation of patent licensing contract | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20171124 |
|
CF01 | Termination of patent right due to non-payment of annual fee |